Stockhub

Vyant Bio, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 September 2022

  • curprev 17:4217:42, 20 September 2022 >Nick 763 bytes +763 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett)..."
Retrieved from "https://stockhub.co/research/Vyant_Bio,_Inc."